Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration.
Panchaud P, Surivet JP, Diethelm S, Blumstein AC, Gauvin JC, Jacob L, Masse F, Mathieu G, Mirre A, Schmitt C, Enderlin-Paput M, Lange R, Gnerre C, Seeland S, Herrmann C, Locher HH, Seiler P, Ritz D, Rueedi G.
Panchaud P, et al. Among authors: seeland s.
J Med Chem. 2020 Jan 9;63(1):88-102. doi: 10.1021/acs.jmedchem.9b01605. Epub 2019 Dec 23.
J Med Chem. 2020.
PMID: 31804829